AXA IM US Enhanced Index Eq QI A £ Acc |
Performance History | 30/06/2023 |
Growth of 1,000 (EUR) |
![]() | Fund | 31.0 | 8.5 | 37.9 | -13.4 | 12.5 |
![]() | +/-Cat | 0.2 | 0.5 | 3.3 | 0.9 | - |
![]() | +/-Idx | -2.3 | -2.0 | 2.4 | 1.2 | - |
Category: US Large-Cap Blend Equity | ||||||
Benchmarks: Morningstar US Large-Mid NR... |
Key Stats | ||
NAV 18/07/2023 | GBP 33.35 | |
Day Change | 0.82% | |
Morningstar Category™ | US Large-Cap Blend Equity | |
ISIN | IE00BD008V73 | |
Fund Size (Mil) 08/05/2025 | USD 1438.33 | |
Share Class Size (Mil) 18/07/2023 | GBP 0.01 | |
Max Initial Charge | - | |
Ongoing Charge 21/02/2025 | 0.36% |
Investment Objective: AXA IM US Enhanced Index Eq QI A £ Acc |
The investment objective of the Fund is to provide long-term capital appreciation with a total return greater than the return of the S&P 500 Index (the “Index”) on a rolling three-year basis. This Sub-Fund will primarily (meaning not less than 75% of its Net Asset Value) invest in equity securities traded principally on Regulated Markets that are issued by companies that have their registered office or carry out a predominant portion of their economic activity (meaning not less than 51%) in the US. It is intended that this Sub-Fund will be substantially fully invested in such equity securities. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Not Disclosed 31/07/2020 | ||
Inception Date 19/11/2013 |
Advertisement |
Benchmarks | |
Fund Benchmark | Morningstar Benchmark |
S&P 500 TR USD | Morningstar US Large-Mid NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for AXA IM US Enhanced Index Eq QI A £ Acc | 30/04/2025 |
|
|
Top 5 Holdings | Sector | % |
![]() | ![]() | 6.75 |
![]() | ![]() | 6.28 |
![]() | ![]() | 5.75 |
![]() | ![]() | 3.53 |
![]() | ![]() | 3.33 |
![]() | ||
![]() ![]() ![]() | ||
AXA IM US Enhanced Index Eq QI A £ Acc |